Thailand’s BioNet-Asia On Developing Domestic Vaccines – An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
BioNet-Asia has carved a path in vaccines research in Thailand that faces the hurdle of attracting private funding while working on establishing proof of concept for pertussis and dengue vaccines. A mix of private capital and multinational alliances have helped nations such as Vietnam, Indonesia and Malaysia build up domestic vaccine capabilities.
You may also be interested in...
Regulation, Reimbursement Notes From Thailand
Thailand’s military junta has made few moves to tackle reimbursement reforms since a coup in May. But the appointment of a cabinet this month may signal action on health care spending levels.
Thai Researchers, MMV Launch Preclinical Look For New Anti-Malaria Compound Targeting Mutant Enzymes
Research into anti-malarial drug effectiveness in Thailand prompts a pre-clinical look at novel compound.
Regulation, Reimbursement Notes From Thailand
Thailand struggles to tackle reimbursement reforms as political tension grips the country following a military coup last week. Still the civil service continues to take decisions on budget and spending plans, but domestic and multinational firms are keeping a wary eye on developments.